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STUDY QUESTION: Is male factor infertility associated with an increased risk of developing diabetes?
SUMMARY ANSWER: The study provides evidence that male factor infertility may predict later occurrence of diabetes mellitus with the
risk being related to the severity of the underlying fertility problem.
WHAT IS KNOWN ALREADY: Previous cross-sectional studies have shown an increased prevalence of comorbidities among infertile
men when compared to controls.
STUDY DESIGN, SIZE, DURATION: In this prospective cohort study, 39 516 men who had since 1994 undergone fertility treatment with
their female partner were identiﬁed from the Danish national IVF register, which includes data on assumed cause of couple infertility (male/
female factor, mixed and unexplained infertility) and type of fertility treatment. With a median follow-up time of 5.6 years, each man was fol-
lowed for diabetes occurrence from enrollment until 31 December 2012 using the National Diabetes Register (NDR). Men with a history of dia-
betes prior to their fertility diagnosis were excluded. Hazard ratios (HR) were estimated by Cox proportional hazard models with age as the
underlying time scale. In addition to analyzing the data for the entire IVF registration period (1994–2012), separate analyses were performed for
men identiﬁed from the ﬁrst (1994–2005) and second (2006–2012) IVF registration period owing to heterogeneity in the reporting of male factor
infertility in these two time periods, because the reason for male factor infertility was not available from the ﬁrst register.
PARTICIPANTS/MATERIALS, SETTING, METHODS: Male factor infertility was identiﬁed from the variable ‘yes’ or ‘no’ from the
ﬁrst IVF register and through a diagnosis code (e.g. oligospermia, azoospermia) from the second IVF register. The reference group was men
with male factor infertility (=‘no’) and those with normal semen quality or sterilized men. Of the included men, 18 499 (46.8%) had male fac-
tor infertility and 21 017 (53.2%) made up the reference group.
MAIN RESULTS AND THE ROLE OF CHANCE: A total of 651 (1.6%) diabetes cases were identiﬁed during the follow-up period. The
adjusted HR’s for diabetes risk among men with male factor infertility when compared to the reference group were HR = 1.08 (95% CI: 0.89,
1.31) and HR = 1.45 (95% CI: 1.06, 1.97) for the ﬁrst and second IVF registration period, respectively. When assessing the effects of individ-
ual causes of male factor infertility, the adjusted HR’s for men with oligospermia, azoospermia and aspermia were HR = 1.44 (95% CI: 1.01,
2.06), HR = 2.10 (95% 1.25, 3.56) and HR = 3.20 (95% CI 1.00, 10.31), respectively.
LIMITATIONS, REASONS FOR CAUTION: We found no increased risk among men identiﬁed from the ﬁrst IVF register, which may
be related to exposure misclassiﬁcation as the reason for male factor infertility was not available from this time period. The NDR does not
distinguish between type 1 and type 2 diabetes.
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WIDER IMPLICATIONS OF THE FINDINGS: These ﬁndings support previous studies that a man’s reproductive and somatic health
are closely intertwined and highlight the importance for further monitoring of these men. Further, implementation of diabetes screening may
be especially relevant among aspermic and azoospermic men.
STUDY FUNDING/COMPETING INTERESTS: This article is part of the ReproUnion collaborative study, co-ﬁnanced by the
European Union, Intereg V Öresund-Kattegat-Skagerrak. None of the authors declare any conﬂict of interest.
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Introduction
Diabetes mellitus (DM) is a complex metabolic disorder characterized
by prolonged hyperglycemia (Zaccardi et al., 2016). In type 1 DM,
which most commonly debuts in childhood, an autoimmune destruc-
tion of the pancreatic beta-cells ultimately leads to insulin destruction.
Type 2 diabetes, which commonly debuts in middle age, is character-
ized by insulin resistance with risk factors mainly related to lifestyle
although family history and genetic polymorphisms also play a role
(Haffner, 1998). Insulin resistance, particularly in combination with
obesity, has been linked to impaired spermatogenesis and increased
sperm DNA damage (Kasturi et al., 2008). The prevalence of DM is
rising and has been associated with overall risk of cardiovascular dis-
ease and mortality, if poorly regulated (Gu et al., 1998). Whether the
occurrence of infertility has changed over time is uncertain, but the
demand for ART has increased (Sallmen et al., 2005; Ferraretti et al.,
2013). Nonetheless, both DM and infertility are common diseases
which may compromise the well-being and have detrimental effects on
the society (Monga et al., 2004; American Diabetes, 2013).
The association between male infertility and future health has been
of interest in recent years (Ventimiglia et al., 2016). The main focus
has been on the risk of testicular and prostate cancer with little focus
on risk of non-malignant chronic diseases (Hotaling and Walsh, 2009;
Walsh et al., 2010). Cross-sectional studies have found that young
men, already at the time of an infertility diagnosis, are less healthy
than their fertile peers suggesting that a man’s reproductive and som-
atic health are closely associated, but whether these ﬁndings have a
direct causation is difﬁcult to determine (Salonia et al., 2009;
Ventimiglia et al., 2015; Eisenberg et al., 2015a). Only one prospect-
ive study evaluated the risk of chronic non-malignant diseases among
infertile men and found a 30% increased risk of diabetes (Eisenberg
et al., 2015b). Importantly low levels of testosterone have been
linked to both diabetes and mortality, suggesting common mechanis-
tic pathways (Laughlin et al., 2008; Rao et al., 2013). In keeping with
this, studies from Europe and the USA have found an association
between poor semen quality and mortality (Groos et al., 2006;
Jensen et al., 2009; Eisenberg et al., 2014).
As men are not subjects of regular health screening programmes as
women are, the contact with the health care provider as part of a fer-
tility evaluation is a unique opportunity to identify men who may be at
increased risk of morbidity, in order to initiate proper preventive
action. In this nationwide prospective cohort study we report on the
risk of developing diabetes in a large population of men identiﬁed in
the Danish National IVF register 1994–2012.
Materials andMethods
Setting
In Denmark, up to three reimbursed fresh IVF or ICSI cycles, and an unlim-
ited number of frozen, thawed embryo transfer cycles and insemination
cycles are offered in the public, tax-ﬁnanced health care system to childless
couples and childless single women younger than 40 years old. In the pri-
vate health care system fertility treatment ﬁnanced by the patient’s them-
selves are offered up to the female age of 45 years. In 2015, 17 181
treatments were initiated with 9% of all Danish children being born after
ART during that year (Danish Fertility Society Annual Report, 2015). The
IVF clinics in Denmark perform a high volume of semen analyses used for
fertility evaluations and sperm preparations for ART. Prior to the start of
treatment, a semen sample was provided by masturbation into sterile con-
tainers as part of the male evaluation. If the ﬁrst semen sample was not
normal the men were generally asked to provide a second sample shortly
after the ﬁrst. Thus, any diagnosis of reduced semen quality (e.g. oligosper-
mia and azoospermia) was generally based on two consecutive tests. The
samples were generally analyzed according to the World Health
Organization guidelines by trained personnel and the men were carefully
instructed regarding abstinence time.
Study population
We created a historic cohort of all men whose partner had undergone fer-
tility treatment between 1 January 1994 and 31 December 2012 with pro-
spective follow-up in the Danish National Diabetes Register (NDR) through
the use of unique personal identiﬁcation numbers held by all Danish citizens,
which enables individual linkage between all national registers (Pedersen,
2011). The identiﬁcation numbers were further used to obtain information
on date of death, emigration or disappearance of the cohort members. The
men had to be born in Denmark, live in Denmark at the time of inclusion,
and be without a prior diabetes diagnosis registered in the NDR.
The baseline examination included age and highest level of school
attendance which can be related to socioeconomic status. The study was
approved by Danish Data Protection Agency J. nr.: BFH-2015-091.
According to the Danish legislation, register-based studies do not require
ethical approval, as these studies do not involve direct contact with
individuals.
Information on fertility status
The men were identiﬁed through the Danish National IVF register which
records each time a woman undergoes a fertility treatment cycle (Andersen
et al., 1999; Blenstrup and Knudsen, 2011). Mandatory by Danish law, all
initiated treatments must be reported to the register. The register was estab-
lished in 1994 and holds information on the reason for infertility (male/female
factor, mixed or unexplained infertility) and of type of infertility treatment
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(IVF, ICSI, oocyte/sperm donation, frozen/fresh embryo transfer). In 2006
the register reporting went from manual to electronic with a more detailed
documentation of the available variables from the latter. From the ﬁrst IVF
register (1994–2005) men were categorized as infertile, identiﬁed from the
variable ‘male factor’ = ‘yes’ or ‘no’ with no missing values. No information
regarding vasectomy or other reasons for male infertility was available in that
registry. From the second IVF register (2006–present) the International
Classiﬁcation of Disease (ICD-10 codes) was used to create the variable for
‘male factor’ = ‘yes’ including the following ICD-10 codes: Aspermia (com-
plete lack of ejaculate, N469A), azoospermia (N469B), oligospermia
(N469C), oligo-teratozospermia (N469D), other reasons for male infertility
(N469W), male infertility unspeciﬁed (N469X). If the female partner was
diagnosed with ‘female infertility associated with male factors (N974)’ and the
identiﬁed partner was not sterilized the men were categorized as ‘male fertil-
ity unspeciﬁed’. Sterilized men (Z302) or those with normal semen quality
(EZDH01) were classiﬁed as ‘male factor = ‘no’ and used as the reference
group. If no diagnosis code was available from the ﬁrst visit, the diagnosis
code of the second visit was used. Men with ﬁctive national identiﬁcation
numbers (foreign citizens and sperm donators), a history of diabetes, from
Greenland or those with an unknown fertility diagnosis (missing ICD-10
code) were excluded.
The Danish National Diabetes Register
The personal identiﬁcation number was used to link the cohort members
to the NDR to identify incident diabetes cases between baseline and either
date of death, emigration, disappearance or end of follow-up (31
December 2012).
The NDR was established in 2006 to describe and monitor the occur-
rence of diabetes in Denmark and provide data for epidemiological
research. The register has previously been described in detail (Carstensen
et al., 2008, 2011). In brief, the NDR links three existing nationwide admin-
istrative records in the Danish Health system. Inclusion criteria include
hospital discharge diagnoses of diabetes in the NDR since 1994; podiatry
for diabetic patients, ﬁve blood glucose measurements within 1 year, or
two blood glucose measurements per year for ﬁve consecutive years, as
registered in the National Health Insurance Register (which contains all
services provided by general and specialist practitioners since 1973); or
two purchases of insulin or oral glucose-lowering drugs within 6 months,
as registered in the Danish National Prescription Register since 1993
(Carstensen et al., 2008, 2011; Kildemoes et al., 2011).
Statistical analysis
First, we examined the cross-sectional association between the prevalence
of male factor infertility and diabetes by logistic regression. Next, we ana-
lyzed the risk of new-onset diabetes according to male factor infertility and
those with missing ICD-10 codes using the occurrence of diabetes in men
from couples who had undergone fertility treatment. Hazard ratio (HR) of
diabetes was calculated using Cox proportional hazards models with age
as the underlying time scale ensuring that risk estimates were based on
individuals at exactly the same age (Thiebaut and Benichou, 2004). We
used left truncation at age of inclusion, so that the men were considered at
risk from inclusion into the cohort, and right censoring at the age of dia-
betes (event), death, emigration, disappearance or end of follow-up on 31
December 2012, whichever came ﬁrst.
Owing to the heterogeneity of the IVF registry data available from the
two time periods, 1994–2005 and 2006–2012, we conducted separate
analyses for assessing the effects of infertility on diabetes within these time
periods in addition to an overall analysis of the entire population. Within
each time period effects were evaluated in two steps: (1) adjusted only for
age as part of the model (crude analysis) and (2) also including calendar
year to adjust for time trends in fertility as well as diabetes incidence over
follow-up time; and full adjustment for highest obtained education, which
is an established proxy for socioeconomic status (Winkleby et al., 1992).
From 2006 and onwards, we estimated the association between the sub-
types of male factor infertility deﬁned according to ICD-10 classiﬁcations
(aspermia, azoospermia, oligospermia, oligo-teratozospermia and other/
unspeciﬁed causes) and diabetes risk, with normal semen quality and
sterilized as the reference groups. The results are expressed as HRs with
two-sided 95% CIs on the basis of the Wald test statistic for regression
parameters in SAS (version 9.2; SAS Institute, Cary, NC, USA).
Results
Among the 53 625 men identiﬁed in the Danish IVF register from 1
January 1994 to 31 December 2012, we excluded 972 men due to a
diabetes record in the NDR before baseline; 918 with ﬁctive identiﬁca-
tion numbers used for sperm donors and foreign citizens; 12 089 with
missing fertility treatment date or a missing fertility diagnosis and 130
men living in Greenland (Fig. 1). The remaining 39 516 men were fol-
lowed up for diabetes for an average of 5.6 years. At baseline, 1.9%
had diabetes. We identiﬁed 651 (1.6%) cases of diabetes (prevalence
rate 2.9 per 1000 person-years) during the follow-up years.
Overall, 18 499 (46.8%) men were diagnosed with male factor infer-
tility for the entire IVF period (1994–2012). Men identiﬁed from the
ﬁrst IVF register (1994–2005) made up 36.1% of the cohort with male
factor infertility identiﬁed in 39.5% of the cases. The second IVF regis-
ter (2006–2012) made up the remaining 63.9% of the cohort with
male factor infertility identiﬁed in 51% of the cases (Table I). The base-
line characteristics across the different IVF registration periods were
similar between those with male factor infertility and the reference
group. The most common type of male factor infertility was oligosper-
mia, with 8538 (33.8%) men, followed by other causes/unspeciﬁed
male factor infertility 2907 (11.4%). The diabetes cases were unevenly
distributed among those with male factor infertility and the reference
group for the two IVF registration periods (Table II).
At baseline, male factor infertility was associated with a higher
prevalence of diabetes among men enrolled from both the ﬁrst IVF
register [odds ratio (OR) 1.57, 95% CI: 1.16, 2.11] and those from the
second IVF register (OR 1.41, 95% CI: 1.20,1.66) after adjustment for
age and education.
The adjusted HR for incident diabetes cases associated with male
factor infertility for the ﬁrst registration period was (HR = 1.08; 95%
CI: 0.89, 1.31), whilst the adjusted HR for the second registration peri-
od was (HR = 1.45; 95% CI: 1.06, 1.97). There appeared to be an
exposure-dependence over the different infertility types, with the
adjusted HR for men with oligospermia, azoospermia and aspermia
being HR = 1.44 (CI: 1.01, 2.06), HR = 2.10 (CI: 1.25, 2.56) and HR =
3.20 (CI: 1.0, 10.31), respectively (Table II). The adjusted HR compar-
ing the men with unknown fertility status (missing ICD-10 codes) to
the reference group was 1.01 (0.72,1.43).
Discussion
Main ﬁndings
Our prospective study of more than 39 000 men identiﬁed from the
Danish National IVF register between 1994 and 2012 found that male
factor infertility was associated with an increased risk of being diagnosed
with diabetes among men identiﬁed from the second IVF register
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(2006–2012). When stratiﬁed by infertility type, we observed an
increased risk across all subtypes with a particularly high risk among
aspermic and azoospermic men. We did not observe an increased risk
among men identiﬁed from the ﬁrst IVF registration period (1994–2005),
which may be due to exposure misclassiﬁcation.
Thus there are important differences between the two IVF registra-
tion periods that warrant mention. In the ﬁrst IVF register male factor
was registered as either ‘yes’ or ‘no’ with no missing values, which may
have the following consequences: ﬁrst, that sterilized men are misclas-
siﬁed as ‘infertile’ (however, as less than 1% of the men are sterilized in
the second register it is unlikely to be the sole explanation) and
second, that men in a gray zone (e.g. subfertile men) may have been
misclassiﬁed as ‘fertile’. Both scenarios would bias the results toward
null and implicitly lead to an underestimation of the diabetes risk
among the infertile. Further, this misclassiﬁcation may explain the sub-
stantially higher percentage of male factor infertility cases from the
second IVF register. Alternatively, limited statistical power owing to
the smaller sample size of the ﬁrst IVF register may also explain the dif-
ferences in the risk estimates between the two registration periods
although this is less likely as the study population still exceeded 14 000
men during the initial follow-up years. Overall, data captured from the
ﬁrst registration period appears less valid especially as the speciﬁc rea-
son for male infertility was not available.
Prior literature and mechanisms
In our cohort, 1.9% of the men had diabetes at baseline. We estimated
the percentage of Danish men with diabetes within the same age group
based on data from NDR and Statistics Denmark and found 1.5% had
diabetes (http://www.diabetes.dk/presse/diabetes-i-tal/det-nationale-
diabetesregister.aspx ; http://statistikbanken.dk).With regards to the
socioeconomic proﬁle of the reference group, 15% had completed pri-
mary school and 13.5% had a higher university degree, which compares
to the national averages of 19% and 11%, respectively (http://
statistikbanken.dk). In line with other studies, our ﬁndings indicate that
couples in ART treatment are more highly educated than the general
population (Hotaling et al., 2012; Bay et al., 2013), which is perhaps
expected as education level is important for both navigating health care
options and the ability to understand treatment regimens (Maitra, 2010),
which are both prerequisites for ART treatment.
Our results are comparable to a US study which reported a 30%
increased risk of diabetes among infertile men (Eisenberg et al., 2015b).
Men identified in the Danish National IVF register
between January 1, 1994-December 31,2012
n = 53,625
Men without a history of diabetes
n = 52,653
972 records due to prior
diagnosis of diabetes
identified in the National
Diabetes register 
Men without a history of diabetes
and true identification numbers
n = 51,735
918 records with fictive
identification numbers
(e.g. sperm donors) 
12,089 records due to missing
treatment date or missing
fertility diagnosis
Study population
n = 39,516
130 records from Greenland
Men with known treatment date and
fertility diagnosis
n = 39,646 
Figure 1 Flow diagram of the cohort in a study of the risk of diabetes according to male factor infertility.
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To our knowledge, no other prospective studies have examined this
area, but several studies have explored the reverse association, with
most studies suggesting a mild impact of diabetes on semen quality
(Jangir and Jain, 2014). Further, diabetes may have its effects on male
reproductive function by endocrine control of spermatogenesis, sperm
maturation and impairment of ejaculation (Jangir and Jain, 2014). We
found a particularly high diabetes risk among azoospermic and
aspermic men. However, as 10–15% of azoospermic men display gen-
etic abnormalities our ﬁndings are perhaps not surprising in this con-
text (Krausz, 2011). Other reasons for azoospermia include
hypogonadotrophic hypogonadism, urogenital infection or chemother-
apy although these factors are more likely to have some impact on
semen quality but not necessarily cause azoospermia (Krausz, 2011;
Nordkap, 2016). Aspermia may be caused by androgen deﬁciency or
............................................................ ..............................................................
.............................................................................................................................................................................................
Table I Baseline characteristics of the cohort in a study of risk of diabetes according to male factor infertility.
Male factor infertilitya Reference groupb
N (%) Median
(ﬁfth–95th percentile)
N (%) Median
(ﬁfth–95th percentile)
All men (1994–2012) (n = 39 516, 100%)
N 18 499 (46.8) 21 017 (53.2)
Age at baseline (years) 33.9 (26.4–45.8) 33.8 (26.3–45.02)
Follow-up time (years) 5.7 (0.65–14.9) 5.3 (0.55–17.1)
Highest level of education
Primary school 2683 (14.9) 3088 (15.2)
High school 1367 (7.6) 1460 (7.2)
Skilled trade 8604 (47.8) 9966 (48.9)
Bachelor degree 2757 (15.3) 3094 (15.2)
Higher University 2594 (14.4) 2756 (13.5)
Men included in IVF register (1994–2005) (n = 14 283, 36.1%)c
N 5642 (39.5) 8641 (60.5)
Age at baseline (years) 33.8 (26.7–45.4) 33.8 (27.2–43.9)
Follow-up time (years) 11.0 (7.2–16.9) 12.4 (7.3–18.0)
Highest level of education
Primary school 922 (16.6) 1435 (16.9)
High school 390 (7.0) 602 (7.1)
Skilled trade 2833 (51.0) 4225 (49.8)
Bachelor degree 781 (14.1) 1221 (14.4)
Higher University 624 (11.2) 995 (11.7)
Men included in IVF register (2006–2012) (n = 25 233, 63.9%)c
N 12 857 (50.9) 12 376 (49.1)
Age at baseline (years) 34.0 (26.2–46.0) 33.7 (25.9–45.7)
Follow-up time (years) 4.32 (0.40–4.3) 2.73 (0.31–6.7)
ICD code
Aspermia 137 (0.5)
Azoospermia 1275 (5.0)
Oligospermia 8538 (33.8)
Other causes/unspeciﬁed 2907 (11.4)
Highest level of education
Primary school 1761 (14.1) 1653 (13.9)
High school 977 (7.8) 858 (7.2)
Skilled trade 5771 (46.3) 5741 (48.3)
Bachelor degree 1976 (15.9) 1873 (15.8)
Higher University 1970 (15.8) 1761 (14.8)
aIncludes men with ‘male factor = yes’ identiﬁed from the ﬁrst IVF register and men classiﬁed with male factor infertility based on following ICD-10 codes: N469A, N469B, N469C,
N469D, N469W, N469X, N974 (if the man was not sterilized) from the second IVF register.
bIncludes men with ‘male factor = no’ identiﬁed from the ﬁrst IVF register and men with either normal semen quality or those vasectomized identiﬁed from the second IVF register.
cRegistration in the Danish IVF registry was updated in 2006 from a manual to electronic system with a more detailed documentation in the recent years.
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retrograde ejaculation, which is a frequent condition among diabetic
men (Fedder et al., 2013). Importantly, these ﬁndings indicate that
some infertile men could have diabetic sequelae even before a diagno-
sis, as men with a history of diabetes were excluded from our cohort.
Nonetheless, as we observed an increased risk across all subtypes of
male factor infertility we also hypothesize that the link between male
factor infertility and diabetes may be, in addition to a hormonal gen-
esis, due to common health/lifestyle factors or shared genetic origins.
Alternatively, some men may have a pre-diabetic condition that has
not yet been diagnosed, which may explain the presence of aspermia
and azoospermia prior to the debut of diabetes.
The association between low testosterone, a potential marker for
male infertility, and diabetes risk has been investigated as testosterone
plays a signiﬁcant role in glucose and lipid metabolism (Kelly and Jones,
2013). Studies have shown that low levels of testosterone may predis-
pose men to type 2 diabetes and metabolic syndrome (cluster of risk
factors associated with an increased risk of heart disease or stroke)
independently of BMI and other established risk factors for insulin
resistance (Laaksonen et al., 2004; Li et al., 2010). Another recent
study concluded testosterone to be a risk marker rather than a risk
factor for subsequent type 2 diabetes as low levels of testosterone and
sex hormone-binding globulin, but not LH, were associated with an
increased risk of the disease (Holmboe et al., 2016). Testosterone,
however, is a nonspeciﬁc marker for infertility/diabetes as low levels are
associated with other conditions, such as cardiovascular disease, obesity
and overall mortality, although conﬂicting results exist (Laughlin et al.,
2008; Kelly and Jones, 2015).
Cross-sectional studies have shown that men with reduced fertility,
already at the time of a fertility evaluation, present with more medical
comorbidities than their fertile peers (Salonia et al., 2009; Ventimiglia
et al., 2015; Eisenberg et al., 2015a). The observation of a higher base-
line prevalence of diabetes among men with male factor infertility is
concordant with this evidence. More speciﬁcally, one US study found
that men with more semen abnormalities had higher rates of endo-
crine and circulatory system diseases (Eisenberg et al., 2015a) whereas
an Italian study found higher rates of rates of oligospermia and azoo-
spermia among men with poorer general health (Salonia et al., 2009).
However, the relationship between male infertility and health is rather
complex as several confounders may affect both. For example, as both
age and smoking are known to affect semen quality (Kidd et al., 2001;
Sharma et al., 2015) and diabetes risk (Biggs et al., 2010), these results
must be interpreted with caution. A genetic link between male infertil-
ity and diabetes may exist as a recent study identiﬁed over 100 genes
associated with both male infertility and several disease mechanisms,
including metabolic disease pathways (Tarin et al., 2015). Further, as
many genes are expressed during male germline cell differentiation, it
seems plausible that possible mutations in this process could lead to
both male infertility and risk of diabetes (Matzuk and Lamb, 2008).
Strengths and limitations
Our study had several advantages including the overall size and possibil-
ity for long-term follow-up through national health registers which
means a minimal number of men were lost to follow-up. In addition, as
the ﬁrst three fresh in vitro treatments are free of charge in Denmark for
childless couples/women younger than 40 years old, we were able to
include men from different socioeconomic backgrounds in contrast to
countries were treatments are expensive and paid for privately, which is
of importance as previous studies have demonstrated a healthy patient
effect among men identiﬁed from infertile couples (Jensen et al., 2009;
Eisenberg et al., 2014). Our study also has limitations. First, we also
relied on two important assumptions: ﬁrst, that men with a diagnosis of
male factor infertility had impaired semen parameters and second, that
men with a diagnosis of normal semen quality had normal semen
............................... ................................
.............................................................................................................................................................................................
Table II Association between male factor infertility and risk of diabetes.
Men at risk, n Cases, n Hazard ratios (95% CI) Hazard ratios (95% CI)
Crudea,b Adjustedmodela,b,c
First IVF period (1994–2005)
Reference 8641 286 1.00 1.00
Male factor infertility 5642 175 1.06 (0.87, 1.27) 1.08 (0.89, 1.31)
Second IVF period (2006–2012)
Reference 12 376 61 1.00 1.00
Male factor infertility 12 857 129 1.42 (1.05, 1.93) 1.45 (1.06, 1.97)
Unknownd 10 078 74 0.99 (0.71, 1.39) 1.01 (0.715, 1.43)
Fertile 12 376 61 1.00 1.00
Oligospermiae 8538 66 1.29 (0.91, 1.83) 1.44 (1.01, 2.063)
Other causes/unspeciﬁed 2907 38 1.31 (0.80, 1.97) 1.60 (1.04, 2.46)
Azoospermia 1275 22 2.31 (1.42, 3.77) 2.10 (1.25, 3.56)
Aspermia 137 3 3.43 (1.07, 10.94) 3.20 (1.00, 10.31)
aAdjusted for age by using it as time scale in the Cox model.
bDue to exclusion of cohort members with a missing value for any covariate, the number of persons is identical in the crude and the adjusted analyses.
cAdjusted for birth calendar year and highest educational level (indicator: primary school/high school/skilled trade/bachelor/university).
dMen with unknown fertility status (missing ICD-10) ICD: International Classiﬁcation of Disease.
eIncludes 30 men with oligoteratospermia.
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parameters, although we recognize that signiﬁcant intra-variability in
semen quality from the same men exist. This could lead to misclassiﬁca-
tion bias especially for the oligospermic men as they may be misclassiﬁed
as ‘fertile’, which would lead our estimates towards null. In keeping with
this, we also acknowledge that although our reference group consisted
of men with normal semen quality or those who had been sterilized,
they still belong to infertile couples which means their reproductive cap-
acity still may be reduced in comparison to men from the general popu-
lation. Further, far from all couples seek medical attention for infertility,
which may limit generalizability. We also excluded men with a prior diag-
nosis of diabetes although it is possible that some men may have an
undetected fertility problem, which actually precedes the diabetes diag-
nosis. We also lacked information regarding pre-hormonal IVF stimula-
tion for male sterility. In Denmark, however, there is no tradition for
administering FSH and/or clomiphene citrate to increase sperm counts.
This applies to men with poor semen quality due to hypogonadotrophic
hypogonadism, but they seldom undergo ART treatment as spontan-
eous pregnancy often is achieved. Among the limitations of NDR is the
lack of information regarding whether the registered diabetes is type 1
or type 2. However, type 2 diabetes generally constitutes ~90% of all
diabetes in this age group; and cohort participants with a diabetes diag-
nosis prior to enrollment were excluded. Further limitations include that
the date of inclusion in the NDR register is only a proxy for the diagno-
sis, which was likely made some time prior to inclusion in the NDR
(Glumer et al., 2003). Also the NDR likely underestimates the actual dia-
betes burden, as people without clinical diagnoses are not included.
Lastly, as our study was register-based insufﬁcient information regarding
health behavioral factors (smoking, alcohol consumption and BMI) was
available. However, by adjustment of socioeconomic factors we expect
to have accounted for some of this possible confounding.
Conclusion
In our cohort of more than 39 000 men identiﬁed from the Danish
National IVF register, male factor infertility was associated with a sig-
niﬁcantly higher risk of diabetes among men identiﬁed from the second
IVF register. Furthermore, we observed a ‘dose–response’ relationship
as the risk of diabetes appeared to increase with the severity of male
factor infertility. We found no increased risk among men identiﬁed
from the ﬁrst IVF register which may be due to exposure misclassiﬁca-
tion as the reason for male factor infertility was not available from this
time period. In line with other studies (Jensen et al., 2009; Salonia
et al., 2009; Eisenberg et al., 2015a), these ﬁndings support an associ-
ation between a man’s reproductive and somatic health. Clinically,
these ﬁndings can help to identify high risk populations where further
monitoring may be necessary, which could include screening for dia-
betes among aspermic and azoospermic men.
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